A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
Feature|Articles|June 23, 2026
Pharmacists Are at the Forefront of Technology in Diabetes Care
Author(s)Ashley Gallagher, MA
Diabetes technology shifts to continuous glucose monitoring, automated insulin delivery, and connected pens, empowering pharmacists to guide safer care.
Advertisement
Advertisement
The landscape of diabetes management is undergoing a profound transformation, moving away from isolated fingerstick readings toward a world of continuous data and automated therapy. Although diabetes technology has historically been divided into insulin administration and glucose measurement, the field now encompasses a complex ecosystem of hardware and software, including continuous glucose monitors (CGMs), automated insulin delivery (AID) systems, and connected insulin pens.1
Related to this article
Eli Lilly’s new indication helps improve medication delivery for adults with type 2 diabetes, reducing annual injections by over 300.
In a review of records assessing patients with type 2 diabetes, researchers provide a comprehensive detail of strategies leading to diabetes remission though gaps persist.
Exploring the effects of weight-loss and GLP-1 therapies, researchers determine the specific metabolic determinants that lead to patients’ weight reduction.
The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
The label expansion adds patients 12 years of age and older to the once daily alopecia areata indication.
Pharmacist and public health expert Jennifer Hammons, PharmD, DrPH, discusses pharmacy as essential infrastructure amid rural pharmacies persistently being overlooked.
An American Heart Association scientific statement shows earlier risk factors and social barriers driving cardiovascular disparities in Hispanic adults.
Advertisement
Advertisement